Accrued Expenses and Other Current Liabilities (Q1) (Tables)

3 Months Ended

12 Months Ended

Mar. 31, 2026

Dec. 31, 2025

Accrued Expenses and Other Current Liabilities

Schedule of accrued liabilities and other current liabilities


(in thousands)			March 31, 2026			December 31, 2025
Professional fees			$500			$347
Compensation and related benefits			1,297			2,740
Research and development			1,174			642
Divestiture fee due to Catalent			924			924
			$3,895			$4,653


(in thousands)			December 31, 2025			December 31, 2024
Professional fees			$347			$406
Compensation and related benefits			2,740			4,405
Research and development			642			1,896
Divestiture fee due to Catalent			924			—
			$4,653			$6,707